Donald K. Stern is Director at NOVELION THERAPEUTICS INC. (NVLN). They have made 1 open-market trade across 1 company since 2017, most recently 2017-06-12.
CIK 0001653128
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $23K since 2017, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| NVLN | 2,500 | $2K |
Shares reported on the most recent Form 4, priced at the 2017-06-13 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| NVLN | BUY | 2017-06-12 | 2017-06-13 | $9.10 | $23K | +21.4% | +7.0% | -18.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.